US20060161247A1 - Tubular prosthesis for external agent delivery - Google Patents

Tubular prosthesis for external agent delivery Download PDF

Info

Publication number
US20060161247A1
US20060161247A1 US11384999 US38499906A US2006161247A1 US 20060161247 A1 US20060161247 A1 US 20060161247A1 US 11384999 US11384999 US 11384999 US 38499906 A US38499906 A US 38499906A US 2006161247 A1 US2006161247 A1 US 2006161247A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
fluid
prosthesis
tubular
outer
member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11384999
Inventor
John Sherry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifeshield Sciences LLC
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having an inflatable pocket filled with fluid, e.g. liquid or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir

Abstract

A tubular prosthesis, which may be an endovascular prothesis, is provided which includes a tubular member (stent or stent/graft combination) and an outer covering having portions sealed to the tubular member. The tubular member is impervious to a pre-determined fluid, particularly an occluding fluid, while the outer cover is pervious to the pre-determined fluid. In one aspect of the present invention, the implantation of the prosthesis allows for occluding fluid to weep from the prosthesis and into a sac of an aneurysm to cause occlusion thereof without introducing the occluding fluid into the blood stream. In this manner, a Type II failure of the prosthesis may be avoided. In other aspects of the invention, therapeutic agents may be delivered and/or a seal may be formed about the prosthesis to prevent a Type I failure.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • [0001]
    This application is a divisional application of U.S. application Ser. No. 09/978,988, filed on Oct. 16, 2001, now allowed, the entire contents of which are hereby incorporated by reference.
  • FIELD OF THE INVENTION
  • [0002]
    This invention relates to tubular prostheses, including, but not limited to, endovascular grafts and stent/grafts, for maintaining patency of blood vessels and treating aortic artery aneurysms, and tubular conduits for maintaining patency in other bodily passageways.
  • BACKGROUND OF THE PRIOR ART
  • [0003]
    It is known in the prior art to use endovascular prostheses to treat aortic artery aneurysms (“AAA”). Such treatment includes implanting a stent, or stent/graft, within the diseased vessel to by-pass the anomaly. An aneurysm is a sac formed by the dilation of the wall of the artery, which may be congenital, but usually is caused by disease and, occasionally, by trauma. With reference to FIG. 1, sac 1 of aneurysm A is defined by dilated portions 2 of aortic artery AA. With the collection of blood and other embolic material in the sac 1, and being subjected to hemodynamic pressure, the aneurysm A may rupture, if untreated, causing internal bleeding.
  • [0004]
    Techniques had been developed in the prior art where diseased portions of a blood vessel, such as with an aneurysm, were ablated and replaced with a prosthetic member, such as that shown in U.S. Pat. No. 4,938,740 to Melbin. This technique, however, required open surgery. As an improvement over this technique, endovascular emplacement techniques have been developed to implant grafts and stent/grafts into a vessel from a remote puncture site, thereby obviating the need for open surgery. For example, as shown in FIG. 1, an endovascular prosthesis 3 (stent or stent/graft) is positioned to by-pass the aneurysm A with ends 4, 5 of the prosthesis being in contiguous contact with healthy portions of the aortic artery AA, the prosthesis 3 having been introduced endovascularly (e.g. with a catheter). Accordingly, if the aneurysm A was to rupture, blood flow through the aortic artery AA would be uninterrupted, and internal bleeding generally avoided.
  • [0005]
    Although considerable success has been enjoyed with stent and stent/graft performance, failures have been noted and predominantly classified in four classes: Types I-IV. Type I failures relate to leaks (referred to as endoleaks) between the vascular prosthesis and the vessel wall. For example, with reference to FIG. 1, a Type I failure would be blood weeping about the end 4 of the prosthesis 3 into the sac 1.
  • [0006]
    A Type II failure involves blood flowing into the aneurysm sac through collateral arteries. Again, with reference to FIG. 1, the sac 1 may be in fluid communication with blood vessels BV, other than the aortic artery AA. Typically, lumbar arteries are in fluid communication (directly or indirectly) with an aneurysm sac. Because blood flow out of the sac 1 is prevented, hemodynamic pressure away from the sac 1 is not present. However, because of hemodynamic pressure within blood vessels in communication with the sac 1, blood flow, nevertheless, is directed into the sac 1 (as shown by arrows). A technique has been developed in the prior art which calls for embolizing the blood vessels BV, such as with embolus coils, thereby isolating the sac 1 from collateral blood flow. However, an additional procedure would be required for embolization.
  • [0007]
    A Type III failure is a mechanical failure, wherein a hole may be ripped into the prosthesis (e.g., excessive wear at a metal/non-metal (fabric or polymer) interface) or poor integrity exists at a connection, or connections, between modular components of a prosthesis, (e.g., extensions may be connected to the prosthesis to obtain improved securement in one or both of the iliac arteries.) For example, as shown in FIG. 1, a hole 6 may be torn into the prosthesis 2, or poor sealing is obtained at the connection between the prosthesis 3 and an extension 7.
  • [0008]
    A Type IV failure relates to excessive prosthesis porosity, wherein blood seeps through the prosthesis regardless of the integrity of sealing and mechanical connections.
  • [0009]
    As can be readily appreciated, even with the successful implantation of an endovascular prosthesis, failures may occur thereafter. It has been found that Type II failures are most prevalent, and may effect up to 30% of all implanted prostheses. Accordingly, there is a clear need for an endovascular prosthesis which can reduce the likelihood, and ideally eliminate, Type II failures.
  • SUMMARY OF THE INVENTION
  • [0010]
    To overcome deficiencies in the prior art, a tubular prosthesis is provided that includes a tubular member, which is impervious to a pre-determined fluid, and an outer covering, which is pervious to the pre-determined fluid. Accordingly, in one aspect of the invention, the prosthesis may be an endovascular prosthesis, and a fluid, which is effective for occluding the sac of an aneurysm, may be introduced by the prosthesis into a space between the tubular member and the outer covering. The fluid will transmit through the outer covering and weep into the sac to cause at least partial occlusion thereof without the occluding fluid being introduced into the blood stream. In this manner, collateral blood flow may be prevented from flowing into the aneurysm sac and collecting therein.
  • [0011]
    A fluid conduit, preferably a microcatheter, is connected to the endovascular prosthesis so as to be in fluid communication with the space defined between the tubular member and the outer covering. It is preferred that the fluid conduit be connected to the prosthesis prior to introduction into the body, with such connection continuing through deployment of the prosthesis and engagement with the vessel. Prior to withdrawal of the deployment device used to implant the prosthesis (e.g. an introducer catheter), occluding fluid is injected through the fluid conduit and between the tubular member and the outer cover with an effective amount of fluid being introduced to achieve at least partial occlusion of the aneurysm sac. With the outer cover being pervious to the fluid, the fluid transmits therethrough. Upon the effective dose having been injected into the space, the fluid conduit is caused to detach from the prosthesis, and withdrawn with any deployment device, such as a guidewire.
  • [0012]
    The tubular member may be of any endovascular prosthetic construction known in the prior art, including graft and stent/graft configurations (including single layer and multi-layer grafts and stent/grafts). The tubular member may be a textile graft, a polymeric graft, or a combination thereof. In addition, the tubular member may have a stent reinforcement (single stent or multiple stents), such stent being self-expanding or expandable by a distensible member, such as a balloon.
  • [0013]
    The outer covering may be formed of a textile, a polymeric film, or a combination thereof. In addition, the outer covering may be made pervious to the occluding fluid through inherent porosity of the constituent material of the outer covering (e.g., porosity of expanded polytetrafluoroethylene (ePTFE)), and/or, more preferably, through cut apertures physically defined in the outer covering. To attempt to achieve even distribution of the occluding fluid, it is desired to make the outer covering increasingly pervious to the fluid at locations further from the fluid conduit.
  • [0014]
    The occluding fluid is preferably a liquid embolic, which may be an alginate, an hyaluronic acid, and/or a cyanoacrylate, or an admixture thereof. Alternatively, a sclerosing agent may be used, as well as cross-linking polymers (polyurethanes, silicones), thrombin, and autologous clot(s). The occluding fluid may be in a liquid state or a gel, and may be formed with solids in a suspension of either state (liquid or gel).
  • [0015]
    In another aspect of the invention, therapeutic agents, with or without the occluding fluid, may be transmitted via the subject invention.
  • [0016]
    The tubular prosthesis may be used as an endovascular prosthesis, as well as, in other applications to maintain patency of a bodily passageway, such as the esophagus, trachea, colon, biliary tract, urinary tract, prostate, and brain.
  • [0017]
    These and other features of the invention would be better understood through a study of the following detailed description and accompanying drawings.
  • BRIEF DESCRIPTION OF DRAWINGS
  • [0018]
    FIG. 1 is a schematic of an aortic artery aneurysm with an endovascular prosthesis by-passing thereby;
  • [0019]
    FIG. 2 shows a first embodiment of a tubular prosthesis of the subject invention;
  • [0020]
    FIG. 3 shows a tubular member for use with the first embodiment of the subject invention;
  • [0021]
    FIG. 4 shows a second embodiment of a tubular prosthesis of the subject invention;
  • [0022]
    FIG. 5 shows a bifurcated Y-shaped tubular member for use with the second embodiment of the subject invention; and
  • [0023]
    FIGS. 6A and 6B are schematics depicting the connections of a fluid conduit to the prosthesis.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0024]
    With reference to FIGS. 2 and 4, first and second embodiments of a prosthesis 10 are respectively depicted therein. Reference will be made herein to the prosthesis being endovascular, although as pointed out above, the prosthesis may be used in other applications. In each embodiment, the endovascular prosthesis 10 includes a tubular member 12, 12 a and an outer covering 14. The tubular member 12, 12 a is impervious to the transmission therethrough of a pre-determined fluid, particularly an occluding fluid, while the outer covering 14 is pervious to the transmission therethrough of the pre-determined fluid. Accordingly, the prosthesis 10 can be utilized to at least partially occlude the sac of an aneurysm, as described below. The endovascular prosthesis 10 may take any shape or form as required, although commonly, the prosthesis 10 will have a cylindrical shape (as shown in FIG. 2), or a bifurcated Y-shape (as shown in FIG. 4). Although only these two shapes are shown, other shapes are possible.
  • [0025]
    The tubular member 12, 12 a may be of any endovascular prosthetic construction known in the prior art, including graft and stent/graft configurations. With reference to FIG. 3, in the first embodiment, the tubular member 12 has a cylindrical shape with a tubular wall 16 having an outer surface 18 and an inner surface 20 defining a single lumen 22. The tubular member 12 need not be formed as a right cylinder, and may be irregularly formed (e.g. bent; eccentric). In a second embodiment, as shown in FIG. 5, the tubular member 12 a has a bifurcated Y-shape with a first tubular portion 16 a, defining a lumen 22 a, from which extend branches 24 a, 24 b, each defining a lumen 26 in fluid communication with the lumen 22 a. As is readily apparent, the tubular member 12, 12 a defines the general shape of the endovascular prosthesis 10, and thus, the tubular member 12, 12 a is formed to any desired shape of the endovascular prosthesis 10.
  • [0026]
    The tubular member 12, 12 a may be a textile graft, a polymeric graft, or a combination thereof (including single layer and multi-layer configurations). In addition, the tubular member 12, 12 a may have a stent reinforcement, such stent being self-expanding or expandable by a distensible member, such as a balloon (stents S are shown in FIG. 5) (a single stent or multiple stents may be used). Graft and stent/graft designs are well known in the art, and any design compatible with the invention may be used. The tubular member 12, 12 a is shown in each embodiment as a unitary member, regardless of shape. As an alternative, the tubular member 12, 12 a may be formed from modular components and/or have the shape as shown, but connected to extensions as known in the prior art (e.g. the extension 7 shown in FIG. 1).
  • [0027]
    The outer covering 14 is disposed on, and preferably sealed to, portions of the outer surface of the tubular member 12, 12 a. In a preferred embodiment, as shown in FIGS. 2 and 4, the outer covering 14 is generally coextensive with the tubular member 12, 12 a. The outer covering 27 is sealed to the tubular member 14 using any technique known to those skilled in the art, including, but not limited to, fusing and bonding. Sealed portions 27 of the outer covering 14 are preferably spaced-apart so that unsealed portions of the outer covering 14 are bounded by the sealed portions 27. In this manner, entrapped space between the tubular member 12, 12 a and the outer covering 14 which is at least partially bounded by the sealed portions 27 of the outer covering 14 defines a pocket 15 for receiving occluding fluid. Optionally, the outer covering 14 can be sealed at multiple locations to define multiple pockets 15. Because of the impervious nature of the tubular member 12, 12 a and the sealed portions 27, the fluid can only escape from the pocket 15 via transmission through the outer covering 14. As shown in FIG. 2, it is preferred to seal the outer covering 14 at portions in proximity to the ends 28 and 30 of the tubular member 12. With respect to the tubular member 12 a, as shown in FIG. 4, it is preferred that the outer covering 14 have sealed portions 27 in proximity to all ends 28 a and 30 a. Accordingly, the pocket 15 is generally coextensive with the tubular member 12, 12 a.
  • [0028]
    As a variation, the outer covering 14 may be formed as a patch which covers only a portion of the tubular member 12, 12 a, as shown in dashed lines in FIG. 2. Although not shown, the outer covering 14 may form an annular band about the tubular member 12, 12 a. Furthermore, multiple outer coverings 14 may be used as patches to form a discontinuous or regular pattern.
  • [0029]
    The outer covering 14 may be formed of a textile, a polymeric film, or a combination thereof. The critical aspect of the outer covering 14 is for it to be pervious to the occluding fluid. The outer covering 14 may be made pervious through inherent porosity of the constituent material of the outer covering, for example due to the porosity of expanded polytetrafluoroethylene (ePTFE). In addition, in a preferred manner of achieving the pervious nature of the outer covering 14, cut apertures 32 may be physically defined in the outer covering 14, as shown in FIG. 4. It is also possible to combine these two approaches.
  • [0030]
    In a preferred embodiment, a fluid conduit 34, preferably a microcatheter, is connected to the endovascular prosthesis 10 so as to convey the occluding fluid thereto. With reference to FIGS. 6 a and 6 b, the fluid conduit 34 may be in direct fluid communication with the pocket 15, with an end 36 of the fluid conduit 34 being located therein. As can be appreciated, to achieve this result, the fluid conduit 34 must breach the sealed portions 27. This can be readily done during manufacturing by causing the sealed portions 27 to be formed about the fluid conduit 34. However, upon removal of the fluid conduit 34, an open passage will be defined through the sealed portions 27. Thus, it is preferred to only use the technique where inherent viscosity of the occluding fluid will prevent leakage of the occluding fluid through the open passage.
  • [0031]
    As a preferred alternative, a valve 38 (preferably one-way) is disposed in communication with the pocket 15, so that the fluid conduit 34 is in indirect communication with the pocket 15 via the valve 38. The construction of the valve 38 and the fluid conduit 34 may be the same as that used with silicone balloon distension, (e.g., the system sold under the trademark “APOLLO” by Target Therapeutics of Fremont, Calif.).
  • [0032]
    In a preferred embodiment, the fluid conduit 34 is connected to the endovascular prosthesis 10 prior to insertion into the human body. After deployment of the endovascular prosthesis 10, using any technique and device known, the fluid conduit 34 preferably remains connected to the prosthesis 10. It is envisioned that a Strecker pull-string type deployment device or a pull-back sheath deployment device would operate well with the subject invention. An effective amount of occluding fluid is conveyed through the fluid conduit 34 into the pocket 15 to at least partially occlude the sac of the aneurysm being treated. With the effective dose having been conveyed, the fluid conduit 34 is caused to be detached, preferably with a sufficiently strong pull of the fluid conduit 34. With the aforementioned prior art silicone balloon distension systems, minimum threshold forces have been developed to achieve such detachment and it is contemplated herein to use similar methodology to require minimum threshold forces for detachment. Once detached, the fluid conduit 34 is removed with any other deployment devices, such as an introducer catheter.
  • [0033]
    The occluding fluid is preferably a liquid embolic, which may be an alginate, an hyaluronic acid, and/or a cyanoacrylate, or an admixture thereof. Alternatively, a sclerosing agent may be used, as well as cross-linking polymers (polyurethanes, silicones), thrombin and autologous clot(s). The occluding fluid may be in a liquid state or gel, and may be formed with solids in a suspension of either state (liquid or gel).
  • [0034]
    With the occluding fluid being disposed within the pocket 15, the fluid may transmit through the outer covering 14 to at least partially occlude the sac of the aneurysm being treated without the fluid being introduced into the blood stream.
  • [0035]
    In another aspect of the invention, therapeutic agents, with or without the occluding fluid, may be transmitted via the subject invention in the same manner described with respect to the occluding fluid, including: anti-thrombogenic agents (such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone); anti-proliferative agents (such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid); anti-inflammatory agents (such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine); antineoplastic/antiproliferative/anti-miotic agents (such as paclitaxel, 5-fluorouracil, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors); anesthetic agents (such as lidocaine, bupivacaine, and ropivacaine); anti-coagulants (such as D-Phe-Pro-Arg chloromethyl keton, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors and tick antiplatelet peptides); vascular cell growth promotors (such as growth factor inhibitors, growth factor receptor antagonists, transcriptional activators, and translational promotors); vascular cell growth inhibitors (such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin); cholesterol-lowering agents; vasodilating agents; and agents which interfere with endogenous vascoactive mechanisms.
  • [0036]
    In a further aspect of the subject invention, the occluding fluid may be introduced via the endovascular prosthesis 10 between the blood vessel wall and the endovascular prosthesis 10 so as to at least partially seal against endoleaks about the prosthesis 10 (i.e., Type I failure). (With other applications of the subject invention, the occluding fluid is disposed between the wall of the bodily passageway and the prostheis 10.) The occluding fluid may create a blood-vessel seal (in whole or in part) with or without occluding the sac of the aneurysm. Preferably, a ring-shaped pocket 15 may be provided in proximity to an end of endovascular prosthesis 10 through which the occluding fluid may be delivered to form the seal; as such, an annular seal may be desirably defined about the prosthesis 10 in proximity to an end so as to restrict endoleaks. The ability to seal against endoleaks is particularly desirable where a blood vessel has an irregularly formed blood vessel.
  • [0037]
    In a further enhancement of the invention, it is preferred that the outer covering 14 be increasingly pervious to the occluding fluid and/or therapeutic agents at further distances from the fluid conduit 34. For example, with reference to FIG. 4, the cut apertures 32 are formed increasingly larger further from the fluid conduit 35 (i.e., as approaching the end 28A) and/or an increasingly greater number of cut apertures 32 is provided further from the fluid conduit 34 (i.e., the density of cut apertures 32 increases with distance from the fluid conduit 34) to provide less resistance to the distribution of the occluding fluid and/or therapeutics being conveyed via the fluid conduit 34. Likewise, the cut apertures 32 are formed increasingly larger and/or greater in number as located further down the branch portion 24 b, to which the fluid conduit 34 is not attached. As an alternative, or as an additional option, the porosity of the constituent material may be gradually increased at further locations from the source of the occluding fluid and/or therapeutic agents to also provide less fluid resistance.
  • [0038]
    Various changes and modifications can be made to the present invention. It is intended that all such changes and modifications come within the scope of the invention as set forth in the following claims.

Claims (28)

  1. 1. A method of occluding a sac of an aneurysm, the method comprising the steps of:
    implanting endovascularly an endovascular prosthesis which by-passes the aneurysm, said endovascular prosthesis including a tubular member having a wall, said wall being impervious to transmission therethrough of an occluding fluid, and an outer covering having portions sealed to said tubular member, said outer covering being pervious to transmission therethrough of said occluding fluid; and
    conveying a dose of occluding fluid into a pocket at least partially defined between said tubular member and said outer covering, said dose being an effective amount to at least partially occlude the sac of the aneurysm, whereby said occluding fluid transmits through said outer covering to at least partially occlude the sac of the aneurysm.
  2. 2. A method as in claim 1 further comprising the step of placing a fluid conduit into fluid communication with said pocket.
  3. 3. A method as in claim 2, wherein the step of conveying a dose of occluding fluid includes conveying said occluding fluid via said fluid conduit.
  4. 4. A method as in claim 2, wherein the step of placing a fluid conduit is performed before the step of implanting endovascularly.
  5. 5. A method as in claim 4, further comprising the step of detaching said fluid conduit from said endovascular prosthesis after the step of conveying a dose of occluding fluid.
  6. 6. A method as in claim 1, wherein said occluding fluid is an embolic liquid selected from the group consisting of alginates, hyaluronic acid, cyanoacrylates, and admixtures thereof.
  7. 7. A method as in claim 1, wherein said occluding fluid is selected from the group consisting of sclerosing agents, polyurethanes, silicones, and admixtures thereof.
  8. 8. A method as in claim 1, wherein said occluding fluid includes thrombin.
  9. 9. A method as in claim 1, wherein said occluding fluid includes an autologous clot.
  10. 10. A method of forming an endovascular prosthesis, the method comprising the steps of:
    providing a tubular member which includes a wall, said wall being impervious to transmission therethrough of a pre-determined fluid; and
    sealing portions of an outer covering to said tubular member, said outer covering being pervious to transmission therethrough of said pre-determined fluid.
  11. 11. A method as in claim 10, further comprising the step of placing a fluid conduit in direct fluid communication with a pocket at least partially defined between said tubular member and said outer covering.
  12. 12. A method as in claim 10, further comprising the step of placing a fluid conduit in indirect fluid communication with a pocket at least partially defined between said tubular member and said outer covering.
  13. 13. A method as in claim 12, wherein the step of placing a fluid conduit includes mounting a valve in fluid communication with said pocket, and connecting said fluid conduit to said valve.
  14. 14. A method as in claim 10, further comprising the step of making said outer covering be pervious to transmission therethrough of said pre-determined fluid.
  15. 15. A method as in claim 14, wherein the step of making includes cutting apertures in said outer covering.
  16. 16. A method as in claim 14, wherein the step of making includes forming said outer covering with porosity.
  17. 17. A method as in claim 10, wherein the step of sealing includes fusing portions of said outer covering to said tubular member.
  18. 18. A method as in claim 10, wherein the step of sealing includes bonding portions of said outer covering to said tubular member.
  19. 19. A method of administering a therapeutic agent, the method comprising the steps of:
    implanting a tubular prosthesis, said prosthesis including a tubular member having a wall, said wall being impervious to transmission therethrough of a pre-determined therapeutic agent, and an outer covering having portions sealed to said tubular member, said outer covering being pervious to transmission therethrough of said pre-determined therapeutic agent; and
    conveying a dose of said pre-determined therapeutic agent into a pocket at least partially defined between said tubular member and said outer covering.
  20. 20. A method as in claim 19, further comprising the step of placing a fluid conduit into fluid communication with said pocket.
  21. 21. A method as in claim 20, wherein the step of conveying a dose of pre-determined therapeutic agent includes conveying said pre-determined therapeutic agent via said fluid conduit.
  22. 22. A method as in claim 20, wherein the step of placing a fluid conduit is performed before the step of implanting endovascularly.
  23. 23. A method as in claim 22, further comprising the step of detaching said fluid conduit from said prosthesis after the step of conveying a dose of pre-determined therapeutic agent.
  24. 24. A method of at least partially forming a seal between a tubular prosthesis and a bodily passageway, the method comprising the steps of:
    implanting a tubular prosthesis into a bodily passageway, said prosthesis including a tubular member having a wall, said wall being impervious to transmission therethrough of an occluding fluid, and an outer covering having portions sealed to said tubular member, said outer covering being pervious to transmission therethrough of said occluding fluid; and
    conveying a dose of occluding fluid into a pocket at least partially defined between said tubular member and said outer covering, said dose being an effective amount to at least partially occlude an area about said tubular member so as to at least partially form a seal between said prosthesis and portions of the bodily passageway.
  25. 25. A method as in claim 24, wherein said occluding fluid is an embolic liquid selected from the group consisting of alginates, hyaluronic acid, cyanoacrylates, and admixtures thereof.
  26. 26. A method as in claim 24, wherein said occluding fluid is selected from the group consisting of sclerosing agents, polyurethanes, silicones, and admixtures thereof.
  27. 27. A method as in claim 24, wherein said occluding fluid includes thrombin.
  28. 28. A method as in claim 24, wherein said occluding fluid includes an autologous clot.
US11384999 2001-10-16 2006-03-20 Tubular prosthesis for external agent delivery Abandoned US20060161247A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09978988 US7033389B2 (en) 2001-10-16 2001-10-16 Tubular prosthesis for external agent delivery
US11384999 US20060161247A1 (en) 2001-10-16 2006-03-20 Tubular prosthesis for external agent delivery

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11384999 US20060161247A1 (en) 2001-10-16 2006-03-20 Tubular prosthesis for external agent delivery

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09978988 Division US7033389B2 (en) 2001-10-16 2001-10-16 Tubular prosthesis for external agent delivery

Publications (1)

Publication Number Publication Date
US20060161247A1 true true US20060161247A1 (en) 2006-07-20

Family

ID=25526588

Family Applications (2)

Application Number Title Priority Date Filing Date
US09978988 Active 2022-10-19 US7033389B2 (en) 2001-10-16 2001-10-16 Tubular prosthesis for external agent delivery
US11384999 Abandoned US20060161247A1 (en) 2001-10-16 2006-03-20 Tubular prosthesis for external agent delivery

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09978988 Active 2022-10-19 US7033389B2 (en) 2001-10-16 2001-10-16 Tubular prosthesis for external agent delivery

Country Status (6)

Country Link
US (2) US7033389B2 (en)
EP (1) EP1435876B1 (en)
JP (1) JP4294483B2 (en)
CA (1) CA2465677C (en)
DE (1) DE60230171D1 (en)
WO (1) WO2003043539A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005760A1 (en) * 2006-07-31 2009-01-01 Richard George Cartledge Sealable endovascular implants and methods for their use
WO2015188775A1 (en) * 2014-06-12 2015-12-17 微创心脉医疗科技(上海)有限公司 Artificial aneurysmal neck and manufacturing method thereof
US9393100B2 (en) 2010-11-17 2016-07-19 Endologix, Inc. Devices and methods to treat vascular dissections
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129215A1 (en) * 1998-09-24 2003-07-10 T-Ram, Inc. Medical devices containing rapamycin analogs
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6602280B2 (en) * 2000-02-02 2003-08-05 Trivascular, Inc. Delivery system and method for expandable intracorporeal device
US6733521B2 (en) 2001-04-11 2004-05-11 Trivascular, Inc. Delivery system and method for endovascular graft
US20040138734A1 (en) * 2001-04-11 2004-07-15 Trivascular, Inc. Delivery system and method for bifurcated graft
US6761733B2 (en) * 2001-04-11 2004-07-13 Trivascular, Inc. Delivery system and method for bifurcated endovascular graft
US7192441B2 (en) * 2001-10-16 2007-03-20 Scimed Life Systems, Inc. Aortic artery aneurysm endovascular prosthesis
US20100016943A1 (en) 2001-12-20 2010-01-21 Trivascular2, Inc. Method of delivering advanced endovascular graft
US7125464B2 (en) 2001-12-20 2006-10-24 Boston Scientific Santa Rosa Corp. Method for manufacturing an endovascular graft section
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7314484B2 (en) * 2002-07-02 2008-01-01 The Foundry, Inc. Methods and devices for treating aneurysms
US7150758B2 (en) * 2003-03-06 2006-12-19 Boston Scientific Santa Rosa Corp. Kink resistant endovascular graft
US20040215335A1 (en) * 2003-04-25 2004-10-28 Brin David S. Methods and apparatus for treatment of aneurysmal tissue
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US8349001B2 (en) * 2004-04-07 2013-01-08 Medtronic, Inc. Pharmacological delivery implement for use with cardiac repair devices
US20060095121A1 (en) * 2004-10-28 2006-05-04 Medtronic Vascular, Inc. Autologous platelet gel on a stent graft
DE102006020687A1 (en) * 2005-07-19 2007-02-08 Aesculap Ag & Co. Kg Stent graft prosthesis for treating abdominal aneurisms and aneurisms of the thoracal aorta comprises a sleeve formed as a folding toroid and having a shape in the unfolded state which fits the shape of the aneurism
US9050091B2 (en) * 2005-07-29 2015-06-09 Cvdevices, Llc Endograft devices and methods for using the same
US8702789B2 (en) 2005-07-29 2014-04-22 Cvdevices, Llc Endoprosthesis assemblies and methods for using the same
GB0616738D0 (en) * 2006-08-23 2006-10-04 Evexar Medical Ltd Improvements in and relating to medical devices
US20080188923A1 (en) * 2007-02-01 2008-08-07 Jack Fa-De Chu Endovascular devices to protect aneurysmal wall
US20080228259A1 (en) * 2007-03-16 2008-09-18 Jack Fa-De Chu Endovascular devices and methods to protect aneurysmal wall
US20080234809A1 (en) * 2007-03-23 2008-09-25 Medtronic Vascular, Inc. Stent Graft System With Injection Tube
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
ES2549000T3 (en) 2009-07-27 2015-10-22 Endologix, Inc. endoprosthesis
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9381326B2 (en) * 2012-06-15 2016-07-05 W. L. Gore & Associates, Inc. Vascular occlusion and drug delivery devices, systems, and methods
KR101424201B1 (en) * 2012-08-14 2014-08-13 이종훈 Stent provided with window and graft thereof

Citations (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4409172A (en) * 1981-02-13 1983-10-11 Thoratec Laboratories Corporation Device and method for fabricating multi-layer tubing using a freely suspended mandrel
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4969458A (en) * 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5078726A (en) * 1989-02-01 1992-01-07 Kreamer Jeffry W Graft stent and method of repairing blood vessels
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5156620A (en) * 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5383926A (en) * 1992-11-23 1995-01-24 Children's Medical Center Corporation Re-expandable endoprosthesis
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5456713A (en) * 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5507769A (en) * 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5522881A (en) * 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US5545135A (en) * 1994-10-31 1996-08-13 Boston Scientific Corporation Perfusion balloon stent
US5558642A (en) * 1991-08-02 1996-09-24 Scimed Life Systems, Inc. Drug delivery catheter
US5562727A (en) * 1994-10-07 1996-10-08 Aeroquip Corporation Intraluminal graft and method for insertion thereof
US5562726A (en) * 1991-10-25 1996-10-08 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
US5607468A (en) * 1994-11-04 1997-03-04 Aeroquip Corporation Method of manufacturing an intraluminal stenting graft
US5618299A (en) * 1993-04-23 1997-04-08 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5628784A (en) * 1994-01-18 1997-05-13 Strecker; Ernst P. Endoprosthesis that can be percutaneously implanted in the body of a patient
US5637086A (en) * 1994-04-29 1997-06-10 Boston Scientific Corporation Method of delivering a therapeutic agent or diagnostic device using a micro occlusion balloon catheter
US5665117A (en) * 1995-11-27 1997-09-09 Rhodes; Valentine J. Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use
US5685847A (en) * 1994-06-30 1997-11-11 Boston Scientific Corporation Stent and therapeutic delivery system
US5693088A (en) * 1993-11-08 1997-12-02 Lazarus; Harrison M. Intraluminal vascular graft
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5785679A (en) * 1995-07-19 1998-07-28 Endotex Interventional Systems, Inc. Methods and apparatus for treating aneurysms and arterio-venous fistulas
US5795331A (en) * 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
US5797951A (en) * 1995-08-09 1998-08-25 Mueller; Edward Gene Expandable support member
US5824038A (en) * 1987-12-08 1998-10-20 Wall; W. Henry Angioplasty stent
US5824054A (en) * 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Coiled sheet graft stent and methods of making and use
US5843033A (en) * 1995-03-31 1998-12-01 Boston Scientific Corporation Multiple hole drug delivery balloon
US5843166A (en) * 1997-01-17 1998-12-01 Meadox Medicals, Inc. Composite graft-stent having pockets for accomodating movement
US5951599A (en) * 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US6096070A (en) * 1995-06-07 2000-08-01 Med Institute Inc. Coated implantable medical device
US6149641A (en) * 1997-08-21 2000-11-21 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
US6193746B1 (en) * 1992-07-08 2001-02-27 Ernst Peter Strecker Endoprosthesis that can be percutaneously implanted in the patient's body
US20010027338A1 (en) * 2000-03-03 2001-10-04 Cook Incorporated Endovascular device having a stent
US6375668B1 (en) * 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6379379B1 (en) * 1998-05-05 2002-04-30 Scimed Life Systems, Inc. Stent with smooth ends
US20020052643A1 (en) * 2000-08-02 2002-05-02 Wholey Michael H. Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms
US6395019B2 (en) * 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US20020169497A1 (en) * 2001-01-02 2002-11-14 Petra Wholey Endovascular stent system and method of providing aneurysm embolization
US6656214B1 (en) * 1995-09-08 2003-12-02 Medtronic Ave, Inc. Methods and apparatus for conformably sealing prostheses within body lumens

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3902364C2 (en) 1988-02-02 1990-10-25 Pfm Plastik Fuer Die Medizin Gmbh, 5000 Koeln, De
US4938740A (en) 1988-05-25 1990-07-03 Trustees Of The University Of Pennsylvania Reducing stress at vascular graft anastomoses
EP0737453A3 (en) 1990-05-18 1997-02-05 Richard S Stack Intraluminal stent
US5411549A (en) 1993-07-13 1995-05-02 Scimed Life Systems, Inc. Selectively expandable, retractable and removable stent
DE69419877T2 (en) 1993-11-04 1999-12-16 Bard Inc C R Fixed vascular prosthesis
DE69527141T2 (en) 1994-04-29 2002-11-07 Scimed Life Systems Inc Stent with collagen
ES2239322T3 (en) 1994-06-27 2005-09-16 Bard Peripheral Vascular, Inc. Polytetrafluoroethylene radially expandable and expandable endovascular stents formed subject.
DE69530891D1 (en) 1994-06-27 2003-07-03 Corvita Corp Bistable luminal graft endoprosthesis
US5591226A (en) 1995-01-23 1997-01-07 Schneider (Usa) Inc. Percutaneous stent-graft and method for delivery thereof
DE69518337D1 (en) 1995-03-10 2000-09-14 Impra Inc Endoluminal stent encapsulated and manufacturing
US5667523A (en) 1995-04-28 1997-09-16 Impra, Inc. Dual supported intraluminal graft
US5628786A (en) 1995-05-12 1997-05-13 Impra, Inc. Radially expandable vascular graft with resistance to longitudinal compression and method of making same
WO1998011847A1 (en) 1996-09-20 1998-03-26 Houser Russell A Radially expanding prostheses and systems for their deployment
US5961545A (en) 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device

Patent Citations (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4409172A (en) * 1981-02-13 1983-10-11 Thoratec Laboratories Corporation Device and method for fabricating multi-layer tubing using a freely suspended mandrel
US4732152A (en) * 1984-12-05 1988-03-22 Medinvent S.A. Device for implantation and a method of implantation in a vessel using such device
US4969458A (en) * 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US5824038A (en) * 1987-12-08 1998-10-20 Wall; W. Henry Angioplasty stent
US5078726A (en) * 1989-02-01 1992-01-07 Kreamer Jeffry W Graft stent and method of repairing blood vessels
US5049132A (en) * 1990-01-08 1991-09-17 Cordis Corporation Balloon catheter for delivering therapeutic agents
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5330500A (en) * 1990-10-18 1994-07-19 Song Ho Y Self-expanding endovascular stent with silicone coating
US5156620A (en) * 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
US5558642A (en) * 1991-08-02 1996-09-24 Scimed Life Systems, Inc. Drug delivery catheter
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5562726A (en) * 1991-10-25 1996-10-08 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
US5456713A (en) * 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US6193746B1 (en) * 1992-07-08 2001-02-27 Ernst Peter Strecker Endoprosthesis that can be percutaneously implanted in the patient's body
US5383926A (en) * 1992-11-23 1995-01-24 Children's Medical Center Corporation Re-expandable endoprosthesis
US5618299A (en) * 1993-04-23 1997-04-08 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5693088A (en) * 1993-11-08 1997-12-02 Lazarus; Harrison M. Intraluminal vascular graft
US5628784A (en) * 1994-01-18 1997-05-13 Strecker; Ernst P. Endoprosthesis that can be percutaneously implanted in the body of a patient
US5795331A (en) * 1994-01-24 1998-08-18 Micro Therapeutics, Inc. Balloon catheter for occluding aneurysms of branch vessels
US5637086A (en) * 1994-04-29 1997-06-10 Boston Scientific Corporation Method of delivering a therapeutic agent or diagnostic device using a micro occlusion balloon catheter
US5522881A (en) * 1994-06-28 1996-06-04 Meadox Medicals, Inc. Implantable tubular prosthesis having integral cuffs
US5685847A (en) * 1994-06-30 1997-11-11 Boston Scientific Corporation Stent and therapeutic delivery system
US5562727A (en) * 1994-10-07 1996-10-08 Aeroquip Corporation Intraluminal graft and method for insertion thereof
US5507769A (en) * 1994-10-18 1996-04-16 Stentco, Inc. Method and apparatus for forming an endoluminal bifurcated graft
US5545135A (en) * 1994-10-31 1996-08-13 Boston Scientific Corporation Perfusion balloon stent
US5607468A (en) * 1994-11-04 1997-03-04 Aeroquip Corporation Method of manufacturing an intraluminal stenting graft
US5843033A (en) * 1995-03-31 1998-12-01 Boston Scientific Corporation Multiple hole drug delivery balloon
US6096070A (en) * 1995-06-07 2000-08-01 Med Institute Inc. Coated implantable medical device
US5785679A (en) * 1995-07-19 1998-07-28 Endotex Interventional Systems, Inc. Methods and apparatus for treating aneurysms and arterio-venous fistulas
US5797951A (en) * 1995-08-09 1998-08-25 Mueller; Edward Gene Expandable support member
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US6656214B1 (en) * 1995-09-08 2003-12-02 Medtronic Ave, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US5665117A (en) * 1995-11-27 1997-09-09 Rhodes; Valentine J. Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use
US6010529A (en) * 1996-12-03 2000-01-04 Atrium Medical Corporation Expandable shielded vessel support
US6270523B1 (en) * 1996-12-03 2001-08-07 Atrium Medical Corporation Expandable shielded vessel support
US5843166A (en) * 1997-01-17 1998-12-01 Meadox Medicals, Inc. Composite graft-stent having pockets for accomodating movement
US5824054A (en) * 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Coiled sheet graft stent and methods of making and use
US5951599A (en) * 1997-07-09 1999-09-14 Scimed Life Systems, Inc. Occlusion system for endovascular treatment of an aneurysm
US6149641A (en) * 1997-08-21 2000-11-21 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
US6395019B2 (en) * 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6379379B1 (en) * 1998-05-05 2002-04-30 Scimed Life Systems, Inc. Stent with smooth ends
US6375668B1 (en) * 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US20010027338A1 (en) * 2000-03-03 2001-10-04 Cook Incorporated Endovascular device having a stent
US6613084B2 (en) * 2000-03-13 2003-09-02 Jun Yang Stent having cover with drug delivery capability
US6379382B1 (en) * 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US20020052643A1 (en) * 2000-08-02 2002-05-02 Wholey Michael H. Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms
US20020169497A1 (en) * 2001-01-02 2002-11-14 Petra Wholey Endovascular stent system and method of providing aneurysm embolization

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090005760A1 (en) * 2006-07-31 2009-01-01 Richard George Cartledge Sealable endovascular implants and methods for their use
US8252036B2 (en) 2006-07-31 2012-08-28 Syntheon Cardiology, Llc Sealable endovascular implants and methods for their use
US9138335B2 (en) 2006-07-31 2015-09-22 Syntheon Cardiology, Llc Surgical implant devices and methods for their manufacture and use
US9827125B2 (en) 2006-07-31 2017-11-28 Edwards Lifesciences Cardiaq Llc Sealable endovascular implants and methods for their use
US9585743B2 (en) 2006-07-31 2017-03-07 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9814611B2 (en) 2007-07-31 2017-11-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US9408607B2 (en) 2009-07-02 2016-08-09 Edwards Lifesciences Cardiaq Llc Surgical implant devices and methods for their manufacture and use
US9566178B2 (en) 2010-06-24 2017-02-14 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
US9393100B2 (en) 2010-11-17 2016-07-19 Endologix, Inc. Devices and methods to treat vascular dissections
US9827093B2 (en) 2011-10-21 2017-11-28 Edwards Lifesciences Cardiaq Llc Actively controllable stent, stent graft, heart valve and method of controlling same
CN105213076A (en) * 2014-06-12 2016-01-06 微创心脉医疗科技(上海)有限公司 Artificial aneurysm neck and production method thereof
WO2015188775A1 (en) * 2014-06-12 2015-12-17 微创心脉医疗科技(上海)有限公司 Artificial aneurysmal neck and manufacturing method thereof

Also Published As

Publication number Publication date Type
US20030074048A1 (en) 2003-04-17 application
JP2005509489A (en) 2005-04-14 application
DE60230171D1 (en) 2009-01-15 grant
EP1435876B1 (en) 2008-12-03 grant
US7033389B2 (en) 2006-04-25 grant
CA2465677A1 (en) 2003-05-30 application
JP4294483B2 (en) 2009-07-15 grant
EP1435876A1 (en) 2004-07-14 application
WO2003043539A1 (en) 2003-05-30 application
CA2465677C (en) 2009-12-15 grant

Similar Documents

Publication Publication Date Title
US6123723A (en) Delivery system and method for depolyment and endovascular assembly of multi-stage stent graft
US7500988B1 (en) Stent for use in a stent graft
US7331985B2 (en) Apparatus and method for deployment of an endoluminal device
US6344052B1 (en) Tubular graft with monofilament fibers
Vorwerk et al. Venous stenosis and occlusion in hemodialysis shunts: follow-up results of stent placement in 65 patients.
US6767358B2 (en) Apparatus for engrafting a blood vessel
US6102938A (en) Endoluminal prosthetic bifurcation shunt
US6004347A (en) Non-migrating vascular prosthesis and minimally invasive placement system therefor
US6440161B1 (en) Dual wire placement catheter
US7306623B2 (en) Branch vessel graft design and deployment method
US6849088B2 (en) Aorto uni-iliac graft
US7025779B2 (en) Endoluminal device having enhanced affixation characteristics
US6827735B2 (en) Endovascular device having a stent
US6428565B1 (en) System and method for edoluminal grafting of bifurcated or branched vessels
US20090210047A1 (en) Stent graft for reinforcement of vascular abnormalities and associated method
US7144421B2 (en) Endovascular prosthesis, system and method
US7232459B2 (en) Thoracic aortic aneurysm stent graft
US5665117A (en) Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use
US20030176912A1 (en) Endovascular graft device and methods for attaching components thereof
US20060212112A1 (en) Graft systems having filling structures supported by scaffolds and methods for their use
US6942692B2 (en) Supra-renal prosthesis and renal artery bypass
US6258115B1 (en) Bifurcated stent and distal protection system
US7267685B2 (en) Bilateral extension prosthesis and method of delivery
US7326237B2 (en) Supra-renal anchoring prosthesis
US7314483B2 (en) Stent graft with branch leg

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACACIA RESEARCH GROUP LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:030694/0461

Effective date: 20121220

AS Assignment

Owner name: LIFESHIELD SCIENCES LLC, TEXAS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACACIA RESEARCH GROUP LLC;REEL/FRAME:030740/0225

Effective date: 20130515